MeiraGTx Holdings PLC reports results for the quarter ended June 30 - Earnings Summary
MeiraGTx Holdings PLC reports results for the quarter ended June 30 - Earnings Summary
MeiraGTx Holdings PLC MGTX.OQ reported quarterly adjusted earnings of 86 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -48 cents. The mean expectation of six analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -60 cents to -8 cents per share.
Revenue rose 8,608.6% to $321.43 million from a year ago; analysts expected $12.48 million.
MeiraGTx Holdings PLC's reported EPS for the quarter was $1.71.
The company reported quarterly net income of $160.67 million.
MeiraGTx Holdings PLC shares had fallen by 4.1% this quarter and gained 63.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 3.2% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for MeiraGTx Holdings PLC is $26.00, about 50.2% above its last closing price of $12.96
This summary was machine generated from LSEG data August 13 at 02:07 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.46 | 0.86 | Beat |
Mar. 31 2026 | -0.40 | -0.57 | Missed |
Dec. 31 2025 | -0.57 | 0.19 | Beat |
Sep. 30 2025 | -0.49 | -0.62 | Missed |
Recent news on MeiraGTx Holdings
See all newsU.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
MeiraGTx gains; reports over $200 mln in license revenue
MeiraGTx Holdings PLC reports results for the quarter ended June 30 - Earnings Summary
MeiraGTx Q2 revenue jumps on Reogen license revenue
Brief: Graviton Bioscience Announces Clearance Of Investigational New Drug For GV101 For Treatment Of Friedreich's Ataxia